A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

Clinical trial NCT04947553 · COMPLETED

Trial details

NCT number: NCT04947553
Sponsor: Axsome Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Agitation in Patients With Dementia of the Alzheimer's Type Alzheimer Disease Agitation, Psychomotor

Start date: 2021-06-17
Primary completion: 2024-12-03
Enrollment: 456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.